Royalty Pharma (RPRX) Competitor Comparison
We are evaluating the key criteria listed to compare Royalty Pharma (RPRX) against its competitors in the Biotechnology industry.
Market Capitalization
8 / 368Gross Profits
10 / 278Total Revenue
6 / 300EBITDA
5 / 337Free Cashflow
350 / 352Quick Ratio
55 / 357Earnings per Share
10 / 359Dividend yield
4 / 6Total Cash
26 / 358Performance 3 years
132 / 368Performance 5 years
169 / 368Performance 10 years
139 / 368Linearity 3 years
51 / 368Linearity 5 years
99 / 368Linearity 10 years
75 / 368Total Rank
38 / 368Dividend Rank
25 / 368Valuation Rank
61 / 368Piotroski Rank
45 / 368Muliplier Rank
110 / 368Valuation Rank - RPRX ranking 61 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.